Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors (Q40158207)

18 September 2017

Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors (English)

1 reference

18 September 2017

0 references

angiogenesis inhibitor

1 reference

Kommareddy S

1

1 reference

PubMed ID

17363959

18 September 2017

Amiji M

series ordinal

2

1 reference

18 September 2017

16 March 2007

1 reference

18 September 2017

1 reference

18 September 2017

14

1 reference

18 September 2017

5

1 reference

18 September 2017

488-498

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701041

18 September 2017

0 references

cites work

Vascular endothelial growth factor, a potent and selective angiogenic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

Gene therapy strategies for treating neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Transfer of genes to humans: early lessons and obstacles to success

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Progress and problems with the use of viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Virus treatment questioned after gene therapy death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Monomolecular collapse of plasmid DNA into stable virus-like particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Drug delivery and transport to solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Gene therapy. Second child in French trial is found to have leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701041

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701041

1 reference

PubMed ID

17363959

Dimensions Publication ID

18 September 2017

0 references

1 reference

PubMed ID

17363959